๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer: a phase II study

โœ Scribed by Allen, M.J.

Book ID
119981064
Publisher
Nature Publishing Group
Year
2000
Tongue
English
Weight
69 KB
Volume
83
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A Phase II trial of intravenous gemcitab
A Phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-ฮฑ in patients with metastatic renal cell carcinoma
โœ Christopher W. Ryan; Nicholas J. Vogelzang; Walter M. Stadler ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 103 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND The objective of this study was to determine the response rate and toxicity of gemcitabine and continuousโ€infusion 5โ€fluorouracil (5โ€FU) in combination with subcutaneous interleukinโ€2 (IL2) and interferonโ€ฮฑ (IFNA) in patients with metastatic renal cell carcinoma. ## METH

Phase II trial of 5-fluorouracil, interf
Phase II trial of 5-fluorouracil, interferon-ฮฑ and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma
โœ Julie A. Ellerhorst; Avishay Sella; Robert J. Amato; Shi-Ming Tu; Randall E. Mil ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 90 KB ๐Ÿ‘ 1 views

## RESULTS. Fifty-five patients were enrolled in the trial and 52 were evaluable for ogy, The University of Texas M. D. Anderson response. All patients experienced fever and flu-like symptoms. Grade 3 or 4 nonhe-Cancer Center, Houston, Texas. matologic toxic effects included hypertension (48%), d